ESCMID eLibrary

Search results
Icon explanation
Icon explanation
close








Found 1 results
-
OS0250A
A phase II randomized double-blind placebo-controlled trial of ganciclovir to prevent cytomegalovirus (CMV) reactivation in acute critical illness ["GRAIL"]
22 April 2017
Session: Late-breaker: Recent clinical trials
Search narrowed by
-
Topics
-
Type of material
-
Time period